NASDAQ : SRTS
Sensus Healthcare, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 2.77 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 45.60M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 46.26M |
| Enterprise Value | 31.42M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 16.46M |
| Shares Outstanding | 16.46M |
| Shares Change (YoY) | +0.39% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 18.67% |
| Owned by Institutions (%) | 25.18% |
| Float | 13.39M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.60 |
| Forward PS | 1.82 |
| PB Ratio | 1.23 |
| P/TBV Ratio | 1.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 8.71 |
| Quick Ratio | 3.90 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -34.83% |
| Return on Assets (ROA) | -16.55% |
| Return on Invested Capital (ROIC) | -53.40% |
| Return on Capital Employed (ROCE) | -35.89% |
| Weighted Average Cost of Capital (WACC) | 11.16% |
| Revenue Per Employee | $291,783 |
| Profits Per Employee | -$258,083 |
| Employee Count | 60 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 0.65 |
Taxes
| Measure | Value |
|---|
| Income Tax | 2.79M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.27 |
| 52-Week Price Change | -14.02% |
| 50-Day Moving Average | 3.04 |
| 200-Day Moving Average | 3.54 |
| Relative Strength Index (RSI) | 39.28 |
| Average Volume (20 Days) | 24,684 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 229,906 |
| Short Previous Month | 227,582 |
| Short % of Shares Out | 1.40% |
| Short % of Float | 1.72% |
| Short Ratio (days to cover) | 10.18 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 17.51M |
| Gross Profit | 6.37M |
| Operating Income | -13.26M |
| Pretax Income | -12.70M |
| Net Income | -15.49M |
| EBITDA | -12.87M |
| EBIT | -13.26M |
| Loss Per Share | -$0.94 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 15.19M |
| Total Debt | 343,000 |
| Net Cash | 14.84M |
| Net Cash Per Share | $0.90 |
| Equity (Book Value) | 36.86M |
| Book Value Per Share | 2.24 |
| Working Capital | 33.35M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -6.80M |
| Capital Expenditures | -173,000 |
| Depreciation & Amortization | 383,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -6.97M |
| FCF Per Share | -$0.42 |
Margins
| Measure | Value |
|---|
| Gross Margin | 36.39% |
| Operating Margin | -75.71% |
| Pretax Margin | -72.53% |
| Profit Margin | -88.45% |
| EBITDA Margin | -73.52% |
| EBIT Margin | -75.71% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.39% |
| Shareholder Yield | -0.39% |
| Earnings Yield | -33.62% |
| FCF Yield | -15.31% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $5.38 |
| Price Target Difference | 91.28% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 8.38% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 8.87 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |